InsidersTradesSigma
Track the Simcere Pharmaceutical Group Ltd. share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Simcere Pharmaceutical Group Ltd. has logged 18 insider filings. Market capitalisation: €32.7bn. The latest transaction was disclosed on 24 July 2026 (Sale). Among the most active insiders: REN Jinsheng. The full history is free.
18
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
13 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,165 of 28,803 companies
68.1
score / 100
Value52
Quality84
FCF yld3.9%
Earn yld4.5%
EV/EBITDA15.6x
ROE19%
Gross mgn82%
Net mgn17%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations18 total
47,000 sharesShareXHKGHKEX:DA20260724E00215
53,000 sharesShareXHKGHKEX:DA20260723E00383
100,000 sharesShareXHKGHKEX:DA20260723E00305
100,000 sharesShareXHKGHKEX:DA20260713E00576
100,000 sharesShareXHKGHKEX:DA20260709E00489
100,000 sharesShareXHKGHKEX:DA20260617E00028
100,000 sharesShareXHKGHKEX:DA20260615E00354
283,334 sharesShareXHKGHKEX:DA20260427E00010
3,000,000 sharesShareXHKGHKEX:DA20260427E00009
44,952,853 sharesShareXHKGHKEX:DA20260413E00571
18 of 18 declarations
About Simcere Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd. is a company focused on the research, development, and commercialization of innovative pharmaceuticals in China. It primarily concentrates on treatments for oncology and autoimmune diseases.